AQEMIA
AQEMIA is a techbio company using generative AI trained on atomic-scale physics to design innovative medicines. Its platform doesn't rely on experimental data, enabling the creation of novel drug candidates. The company has achieved preclinical successes and collaborations with major pharmaceutical firms.
Funding Round:
Funding Amount: $38M
Date: 10-Dec-2024
Investors: Cathay Innovation, Wendel, Bpifrance Large Venture, Eurazeo, Elaia
Markets: Biotech, AI, Drug Discovery
HQ: Paris, Île-de-France, France
Founded: 2019
Website: https://www.aqemia.com
LinkedIn: https://www.linkedin.com/company/aqemia/?originalSubdomain=fr
Twitter: https://twitter.com/aqemia
Crunchbase: https://www.crunchbase.com/organization/aqemia
Leave a Comment
Comments
No comments yet.